We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Consumers look to generic drugs for their cheaper price tags. But a new study finds sudden price spikes for generics are becoming more common. Read More
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is seeking industry feedback on a potential no-deal Brexit scenario in which the agency would function as a medicine and medical device regulator on its own. Read More
Westminster Pharmaceuticals and CVS committed fraud in knowingly selling adulterated thyroid drugs, according to a class-action federal lawsuit. Read More
“Cutting list prices and rolling back proposed increases in particular are an unprecedented recognition of the fundamental changes going on in drug markets,” said Dan Best, senior advisor to the HHS Secretary for drug pricing reform. Read More
“Bringing transparency to drug pricing and educating the public about the cost of their prescriptions is common sense,” said Sen. Chuck Grassley (R-Iowa). Read More
A judge threw out the state of New Jersey’s claims that Purdue Pharma created a public nuisance, but allowed several of its charges that the company violated the False Claims Act and the CFA, the state’s consumer fraud law. Read More
PhRMA has filed an updated version of its lawsuit against California’s drug pricing transparency law, providing specifics the court said its initial complaint lacked. Read More